Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer related death worldwide. Its diagnosis at early stages would significantly improve the survival of CRC patients. The humoral immune response has been demonstrated useful for cancer diagnosis, predating clinical symptoms up to 3 years. Here, we employed an in-depth seroproteomic approach to identify proteins that elicit a humoral immune response in CRC patients. The seroproteomic approach relied on the immunoprecipitation with patient-derived autoantibodies of proteins from CRC cell lines with different metastatic properties followed by LC-MS/MS. After bioinformatics, we focused on 31 targets of CRC autoantibodies. After WB and IHC validation, ERP4...
Colorectal cancer (CRC) is the second most common malignancy in the western world. Early detection a...
To discover serological colorectal cancer (CRC) markers, we analyzed cell line secretome to gather p...
Colorectal cancer (CRC) is the second most common malignancy in the western world. Early detection a...
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer relat...
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer relat...
48 p.-1 graph. abst.-5 fig.-2 tab.-2 fig supl.-6 tab. supl.Colorectal cancer (CRC) is the third most...
In developed countries, colorectal cancer (CRC) is a leading cause of cancer. Because this disease d...
Characterization of the colon cancer immunome and its autoantibody signature from differentially-rea...
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients ...
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients ...
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients ...
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients ...
Colorectal cancer (CRC) is an important public health problem both internationally and in New Zealan...
<div><p>Colorectal cancer (CRC) is the second most common malignancy in the western world. Early det...
Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide. The 5-year su...
Colorectal cancer (CRC) is the second most common malignancy in the western world. Early detection a...
To discover serological colorectal cancer (CRC) markers, we analyzed cell line secretome to gather p...
Colorectal cancer (CRC) is the second most common malignancy in the western world. Early detection a...
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer relat...
Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer relat...
48 p.-1 graph. abst.-5 fig.-2 tab.-2 fig supl.-6 tab. supl.Colorectal cancer (CRC) is the third most...
In developed countries, colorectal cancer (CRC) is a leading cause of cancer. Because this disease d...
Characterization of the colon cancer immunome and its autoantibody signature from differentially-rea...
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients ...
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients ...
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients ...
A Crohn’s-like lymphoid reaction (CLR) is observed in about 15% of colorectal cancer (CRC) patients ...
Colorectal cancer (CRC) is an important public health problem both internationally and in New Zealan...
<div><p>Colorectal cancer (CRC) is the second most common malignancy in the western world. Early det...
Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide. The 5-year su...
Colorectal cancer (CRC) is the second most common malignancy in the western world. Early detection a...
To discover serological colorectal cancer (CRC) markers, we analyzed cell line secretome to gather p...
Colorectal cancer (CRC) is the second most common malignancy in the western world. Early detection a...